01
Cash & equivalents increased 1084.7%
Cash & equivalents changed +1084.7% from the comparable as-filed period.
$4.5M→$53.4MComparable → current
· Pharmaceutical Preparations
RESEARCH SNAPSHOTProMIS Neurosciences Inc.'s latest supported as-filed period reports net income of -$11.7M, 15.9% below the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +1084.7% from the comparable as-filed period.
Net income changed -15.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Operating income changed -20.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
PMN · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001104659-26-095905SEC ↗10-QAug 13, 2026Period Jun 30, 20260001104659-26-095895SEC ↗4Aug 7, 2026Period Aug 5, 20260001104659-26-092673SEC ↗8-KJul 28, 2026Period Jul 28, 20260001104659-26-087269SEC ↗4May 22, 2026Period May 20, 20260001104659-26-065775SEC ↗4May 22, 2026Period May 20, 20260001104659-26-065774SEC ↗4May 22, 2026Period May 20, 20260001104659-26-065772SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 5, 2026Filed Aug 7, 2026 | Kaplan JohanneChief Development Officer | Open Market PurchaseDirect | 2,280 | $13 | $30,324 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Research & development changed +8.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Stock-based compensation changed +92.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001104659-26-065771